OverviewSuggest Edit

Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa. The company’s product portfolio includes central nervous system, cardiovascular, pain, respiratory, anti-retroviral (for state tenders), metabolic, and anti-infective products. It markets and sells its products to health care professionals.
A well integrated pharma company, Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues. Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations. Our customers include premium multi-national companies.. With multiple facilities approved by leading regulatory agencies such as USFDA, EU GMP, UK MHRA, South Africa-MCC, Health Canada and Brazil ANVISA, Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India.

TypePublic
Founded1986
HQHyderabad, IN
Websiteaurobindo.com
Employee Ratings3.9

Latest Updates

Employees (est.) (Sept 2020)18,469(+4%)
Share Price (Jun 2021)₹959(-6%)
Cybersecurity ratingBMore

Key People/Management at Aurobindo Pharma

M. Sivakumaran

M. Sivakumaran

Whole Time Director
K. Ragunathan

K. Ragunathan

Independent Director & Non-Executive Chairman
M. Madan Mohan Reddy

M. Madan Mohan Reddy

Whole Time Director
K. Nityananda Reddy

K. Nityananda Reddy

Whole Time Director & Vice Chairman
N. Govindarajan

N. Govindarajan

Managing Director
M. Sitarama Murthy

M. Sitarama Murthy

Independent Director
Show more

Aurobindo Pharma Office Locations

Aurobindo Pharma has offices in Hyderabad and South Brunswick Township
Hyderabad, IN (HQ)
Hitech City Rd
Hyderabad, IN
Maitri Vihar Commercial Complex
South Brunswick Township, NJ, US
6 Wheeling Rd, Dayton
Show all (3)

Aurobindo Pharma Financials and Metrics

Aurobindo Pharma Revenue

Market capitalization (4-Jun-2021)

561.9b

Closing stock price (4-Jun-2021)

959.0
Aurobindo Pharma's current market capitalization is ₹561.9 b.
Show all financial metrics

Aurobindo Pharma Acquisitions / Subsidiaries

Company NameDateDeal Size
SandozSeptember 07, 2018$900 m

Aurobindo Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Aurobindo Pharma Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Aurobindo Pharma Online and Social Media Presence

Embed Graph

Aurobindo Pharma News and Updates

Aurobindo Pharma Q4 Review - Higher R&D Spend Offsets Benefit Of Better Operating Leverage: Motilal Oswal

Aurobindo Pharma Q4 Review - Higher R&D Spend Offsets Benefit Of Better Operating Leverage: Motilal Oswal

JPMorgan Makes A Case For Aurobindo Pharma Stock’s Re-Rating

The Hyderabad-based drugmaker’s stock rose as much as 2.7% to Rs 1,014, just shy of its all-time high, with high trading volume.

Aurobindo Pharma Q3 Review - Progress On New Ventures Continues: ICICI Direct

Aurobindo Pharma Q3 Review - Progress On New Ventures Continues: ICICI Direct

Aurobindo Pharma Q3 Results: Net Profit Jumps Fourfold On One-Offs; Shares Drop

Aurobindo Pharma’s U.S. business contributed nearly half of its consolidated revenue in the third quarter.

Aurobindo Pharma and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF

HYDERABAD, India, Dec. 24, 2020 /PRNewswire/ -- COVAXX's UB-612 is the first multitope, synthetic peptide-based COVID-19 vaccine candidate in clinical trials and it utilizes normal refrigeration (no freezing required) for distribution Agreement leverages Aurobindo's existing development,...
Show more

Aurobindo Pharma Frequently Asked Questions

  • When was Aurobindo Pharma founded?

    Aurobindo Pharma was founded in 1986.

  • Who are Aurobindo Pharma key executives?

    Aurobindo Pharma's key executives are M. Sivakumaran, K. Ragunathan and M. Madan Mohan Reddy.

  • How many employees does Aurobindo Pharma have?

    Aurobindo Pharma has 18,469 employees.

  • Who are Aurobindo Pharma competitors?

    Competitors of Aurobindo Pharma include Siegfried Holding, Unither Pharmaceuticals and Merz North America.

  • Where is Aurobindo Pharma headquarters?

    Aurobindo Pharma headquarters is located at Hitech City Rd, Hyderabad.

  • Where are Aurobindo Pharma offices?

    Aurobindo Pharma has offices in Hyderabad and South Brunswick Township.

  • How many offices does Aurobindo Pharma have?

    Aurobindo Pharma has 3 offices.